EPA faces suit over plan to release genetically engineered mosquitoes
By Rachel Franzin,
The Hill
| 06. 15. 2020
The Center for Food Safety, the International Center for Technology Assessment and Friends of the Earth allege that the EPA violated the law.
The Environmental Protection Agency (EPA) is facing a lawsuit over its approval of a plan to release genetically modified mosquitoes in Florida and Texas.
Several groups, including the Center for Food Safety, the International Center for Technology Assessment and Friends of the Earth filed a notice of intent to sue on Friday. They alleged that the EPA violated the law by failing to consult with wildlife agencies before determining that the mosquitoes will not pose risks to threatened species.
“EPA’s ‘no effect’ findings and failure to consult are arbitrary and capricious and violate the ESA [Endangered Species Act] because they fail to follow the ESA’s mandated procedures, fail to use the best scientific and commercial data available, fail to consider significant aspects of the issue, and offer an explanation that runs counter to the evidence before the agency,” the groups claimed in their notice.
The EPA last month approved an experimental use permit for a company that wants to test the use of genetically engineered mosquitoes as a way to try to reduce mosquito populations and protect people from mosquito-borne illnesses.
According...
Related Articles
By Aisha Down, The Guardian | 11.10.2025
It has been an excellent year for neurotech, if you ignore the people funding it. In August, a tiny brain implant successfully decoded the inner speech of paralysis patients. In October, an eye implant restored sight to patients who had...
By Jessica Hamzelou, MIT Technology Review | 11.07.2025
This week, we heard that Tom Brady had his dog cloned. The former quarterback revealed that his Junie is actually a clone of Lua, a pit bull mix that died in 2023.
Brady’s announcement follows those of celebrities like Paris...
By Heidi Ledford, Nature | 10.31.2025
Late last year, dozens of researchers spanning thousands of miles banded together in a race to save one baby boy’s life. The result was a world first: a cutting-edge gene-editing therapy fashioned for a single person, and produced in...
By Lauran Neergaard, AP News | 11.03.2025
WASHINGTON (AP) — The first clinical trial is getting underway to see if transplanting pig kidneys into people might really save lives.
United Therapeutics, a producer of gene-edited pig kidneys, announced Monday that the study’s initial transplant was performed successfully...